- Home
- GENK vs ANVS Comparison
GENK vs ANVS Comparison
Compare GENK & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- ANVS
- Stock Information
- Founded
- GENK 2011
- ANVS 2008
- Country
- GENK United States
- ANVS United States
- Employees
- GENK N/A
- ANVS N/A
- Industry
- GENK Restaurants
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- GENK Consumer Discretionary
- ANVS Health Care
- Exchange
- GENK Nasdaq
- ANVS Nasdaq
- Market Cap
- GENK 27.9M
- ANVS 31.2M
- IPO Year
- GENK 2023
- ANVS 2020
- Fundamental
- Price
- GENK $5.32
- ANVS $1.48
- Analyst Decision
- GENK Strong Buy
- ANVS Strong Buy
- Analyst Count
- GENK 3
- ANVS 5
- Target Price
- GENK $12.17
- ANVS $37.00
- AVG Volume (30 Days)
- GENK 200.8K
- ANVS 257.8K
- Earning Date
- GENK 03-06-2025
- ANVS 05-12-2025
- Dividend Yield
- GENK N/A
- ANVS N/A
- EPS Growth
- GENK 62.05
- ANVS N/A
- EPS
- GENK 0.13
- ANVS N/A
- Revenue
- GENK $208,380,000.00
- ANVS N/A
- Revenue This Year
- GENK $20.99
- ANVS N/A
- Revenue Next Year
- GENK $21.14
- ANVS N/A
- P/E Ratio
- GENK $43.37
- ANVS N/A
- Revenue Growth
- GENK 15.12
- ANVS N/A
- 52 Week Low
- GENK $5.00
- ANVS $1.43
- 52 Week High
- GENK $13.12
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- GENK 42.73
- ANVS 30.83
- Support Level
- GENK $5.71
- ANVS $1.43
- Resistance Level
- GENK $6.50
- ANVS $2.07
- Average True Range (ATR)
- GENK 0.43
- ANVS 0.14
- MACD
- GENK -0.03
- ANVS 0.04
- Stochastic Oscillator
- GENK 19.18
- ANVS 7.03
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.